|
Artinian LR, Ding JM, Gillette MU. Carbon monoxide
and nitric oxide: interacting messengers in muscarinic singnaling to the
brain's circadian clock. Exp Neurol. 2001;171(2):293-300. Ávila-Agüero ML, Paris MM, Hu S, Peterson
PK, et al. Systemic cytokine response in children bitten by snakes
in Costa Rica. Pediatr Emerg Care. 2001;17(6):425-429. Chao CC, Gekker G, Sheng WS, Hu S, Peterson PK.
U50488 inhibits HIV-1 expression in acutely infected monocyte-derived
macrophages. Drug Alcohol Depend. 2001;62(2):149-154. Cheeran MC, Hu S, Yager SL, Gekker G, Peterson
PK, Lokensgard JR. Cytomegalovirus induces cytokine and chemokine
production differentially in microglia and astrocytes: antiviral implications.
J Neurovirol. 2001;7(2):135-147. Erice A, Li W, Balfour HH Jr, Boies LR Jr, Melroe H,
Henry K. Analysis of HIV-1 reverse transcriptase and protease sequences
in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals.
AIDS. 2001;15(7):831-836. Gekker G, Lokensgard JR, Peterson PK. Naltrexone
potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte
cultures. Drug Alcohol Depend. 2001;64(3):257-263. Henry K, Wallace RJ, Bellman PC, et al. Twice-daily
triple nucleoside intensification treatment with lamivudine-zidovudine
plus abacavir sustains suppression of human immunodeficiency virus type
1: results of the TARGET Study. J Infect Dis. 2001;183(4):571-578. Henry K. Lessons about AIDS and the circle of
life. Minn Med. 2001;84(2):10-12. Kakuda TN, Page LM, Anderson PL, Henry K, et
al. Pharmacological basis for concentration-controlled therapy with zidovudine,
lamivudine, and indinavir. Antimicrob Agents Chemother. 2001;45(1):236-242. Kempainen R, Nelson K, Williams DN, Hedemark L.
Mycobacterium tuberculosis disease in Somali immigrants in Minnesota.
Chest. 2001;119(1):176-180. (Also listed under Pulmonary and Critical
Care Medicine) Lokensgard JR, Hu S, Hegg CC, Thayer SA, Gekker
G, Peterson PK. Diazepam inhibits HIV-1 Tat-induced migration of human
microglia. J Neurovirol. 2001;7(5):481-486. Lokensgard JR, Hu S, Sheng W, vanOijen
M, Cox D, Cheeran MC, Peterson PK. Robust expression of TNF-alpha,
IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive
infection with herpes simplex virus. J Neurovirol. 2001;7(3):208-219. Niederman MS, Mandell LA, Peterson PK, Yu VL.
Guidelines, pathogens, and resistance: selecting a management strategy
for inpatient community-acquired pneumonia. Med Crossfire. 2001;3:41-52. Peterson PK, Fox HS. Neuroaids: retroviral pathology
and drugs of abuse. Adv Exp Med Biol. 2001;493:259-261. Peterson PK, Gekker G, Hu S, Portoghese PS, Sheng
WS, Lokensgard JR. Targeting the brain's immune system: a psychopharmacological
approach to central nervous system infections. Adv Exp Med Biol. 2001;493:1-6.
Peterson PK, Gekker G, Hu S, Portughese PS, Sheng
WS, Lokensgard JR. Targeting the brain's immune system: a psychopharmacological
approach to central nervous system infections. In: Friedman H, Klein TW,
Madden JJ, eds. Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases.
New York: Kluwer Academic/Plenum Publishers; 2001. Peterson PK, Gekker G, Lokensgard JR, Bidlack
JM, Chang A-C, Portoghese PS. Kappa-opioid receptor agonist suppression
of HIV-1 expression in CD4+ lymphocytes. Biochem Pharmacol. 2001;61(9):1145-1151. Ross L, Henry K, Paar D, et al. Thymidine-analog
and multi-nucleoside resistance mutations are observed in both zidovudine-naive
and zidovudine-experienced subjects with viremia after treatment with
stavudine-containing regimens. J Hum Virol. 2001;4(4):217-222. Ross L, Scarsella A, Raffanti S, Henry K, et
al. Thymidine analog and multinucleoside resistance mutations are associated
with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated
from zidovudine-naive patients experiencing viremia on stavudine-containing
regimens. AIDS Res Hum Retroviruses. 2001;17(12):1107-1115. Sharp BM, McAllen K, Gekker G, Shahabi NA, Peterson
PK. Immunofluorescence detection of delta opioid receptors (DOR) on
human peripheral blood CD4+ T cells and DOR-dependent suppression of HIV-1
expression. J Immunol. 2001;167(2):1097-1102. Sheng WS, Hu S, Ding JM, Chao CC, Peterson
PK. Cytokine expression in the mouse brain in response to immune activation
by Corynebacterium parvum. Clin Diagn Lab Immunol. 2001;8(2):446-448. Tebas P, Henry K, Nease R, Murphy R, Phair J,
Powderly WG. Timing of antiretroviral therapy. Use of Markov modeling
and decision analysis to evaluate the long-term implications of therapy.
AIDS. 2001;15(5):591-599. Verbiest W, Brown S, Cohen C, Conant M, Henry K, et al. Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study. AIDS. 2001;15(5):647-650.
|
